Anlotinib: A Novel Molecular-Targeted Drug for Tumours

Na, JT; Liu, XY; Sun, XJ; Fan, DF; Qian, ZB; Yao, M; Pan, L; He, ZQ; Liu, QQ; Shen, Z; Jiao, R; Lin, X; Gan, L; Li, GY; Zhong, LP

Li, GY; Zhong, LP (通讯作者)，Guangxi Med Univ, Natl Ctr Int Res Biotargeting Theranost, Collaborat Innovat Ctr Targeting Tumor Diag & Ther, State Key Lab Targeting Oncol,Guangxi Key Lab Biot, Nanning 530021, Guangxi, Peoples R China.;Li, GY (通讯作者)，Guangdong Univ Petrochem Technol, Coll Chem, Maoming 525000, Guangdong, Peoples R China.;Zhong, LP (通讯作者)，Guangxi Med Univ, Pharmaceut Coll, Nanning 530021, Guangxi, Peoples R China.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2023; 19 (6): 897

Abstract

Anlotinib is a tyrosine kinase inhibitor. It inhibits tumour growth by inhibiting the phosphorylation of angiogenesis-related receptors and attenuatin......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索